Literature DB >> 26629318

Klotho in cardiovascular disease: Current and future perspectives.

Javier Donate-Correa1, Ernesto Martín-Núñez1, Carmen Mora-Fernández1, Mercedes Muros-de-Fuentes1, Nayra Pérez-Delgado1, Juan F Navarro-González1.   

Abstract

Protein Klotho, beyond its role as a regulator of the phosphatemia, is also involved in the maintaining of the cardiovascular health, being associated its alterations with the development of cardiovascular damage and increased morbi-mortality. For all this, nowadays Klotho is the subject of a thorough research which is focused on uncover its intimate mechanisms of action, and in analyzing the utility of its modulation as a potential strategy with clinical applicability. Molecular mechanisms of Klotho are not well understood but an emerging research area links Klotho deficiency with vascular pathology. Changes in this protein have been associated with cardiovascular-related complications like inflammation, vascular calcification, and endothelial dysfunction. All this is particularly relevant if considering the recent discovery of Klotho expression in vascular tissue.

Entities:  

Keywords:  Cardiovascular disease; Chronic kidney disease; Klotho; Mechanism of action; Therapeutics

Year:  2015        PMID: 26629318      PMCID: PMC4656911          DOI: 10.4331/wjbc.v6.i4.351

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  66 in total

1.  Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system.

Authors:  Hiroshi Tsujikawa; Yoko Kurotaki; Toshihiko Fujimori; Kazuhiko Fukuda; Yo-Ichi Nabeshima
Journal:  Mol Endocrinol       Date:  2003-10-03

2.  Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23.

Authors:  Xijie Yu; Omar A Ibrahimi; Regina Goetz; Fuming Zhang; Siobhan I Davis; Holly J Garringer; Robert J Linhardt; David M Ornitz; Moosa Mohammadi; Kenneth E White
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

Review 3.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

4.  Severely reduced production of klotho in human chronic renal failure kidney.

Authors:  N Koh; T Fujimori; S Nishiguchi; A Tamori; S Shiomi; T Nakatani; K Sugimura; T Kishimoto; S Kinoshita; T Kuroki; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  2001-02-02       Impact factor: 3.575

5.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block.

Authors:  Peggy Kirstetter; Kristina Anderson; Bo T Porse; Sten Eirik W Jacobsen; Claus Nerlov
Journal:  Nat Immunol       Date:  2006-09-03       Impact factor: 25.606

6.  Phosphate regulation of vascular smooth muscle cell calcification.

Authors:  S Jono; M D McKee; C E Murry; A Shioi; Y Nishizawa; K Mori; H Morii; C M Giachelli
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

Review 7.  Overview of the FGF23-Klotho axis.

Authors:  Makoto Kuro-o
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

8.  Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides.

Authors:  Osamu Tohyama; Akihiro Imura; Akiko Iwano; Jean-Noël Freund; Bernard Henrissat; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

9.  Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.

Authors:  Majd A I Mirza; Anders Larsson; Håkan Melhus; Lars Lind; Tobias E Larsson
Journal:  Atherosclerosis       Date:  2009-05-21       Impact factor: 5.162

10.  Klotho is a serum factor related to human aging.

Authors:  Neng-ming Xiao; Yan-ming Zhang; Quan Zheng; Jun Gu
Journal:  Chin Med J (Engl)       Date:  2004-05       Impact factor: 2.628

View more
  6 in total

Review 1.  The Protective Role of Klotho in CKD-Associated Cardiovascular Disease.

Authors:  Xianjin Bi; Ke Yang; Bo Zhang; Jinghong Zhao
Journal:  Kidney Dis (Basel)       Date:  2020-08-19

2.  Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.

Authors:  Yansheng Yao; Yanbing Wang; Yibo Zhang; Chang Liu
Journal:  Lipids Health Dis       Date:  2017-04-13       Impact factor: 3.876

Review 3.  Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression.

Authors:  Jiaqi Tang; Cody C Gifford; Rohan Samarakoon; Paul J Higgins
Journal:  Cancers (Basel)       Date:  2018-05-25       Impact factor: 6.639

4.  Correlation between KLOTHO gene and mild cognitive impairment in the Uygur and Han populations of Xinjiang.

Authors:  Palida Abulizi; Xiao-Hui Zhou; Kabinuer Keyimu; Mei Luo; Feng-Qing Jin
Journal:  Oncotarget       Date:  2017-09-06

Review 5.  Role of Klotho in Chronic Calcineurin Inhibitor Nephropathy.

Authors:  Kang Luo; Sun Woo Lim; Yi Quan; Sheng Cui; Yoo Jin Shin; Eun Jeong Ko; Byung Ha Chung; Chul Woo Yang
Journal:  Oxid Med Cell Longev       Date:  2019-10-17       Impact factor: 6.543

Review 6.  From "Kidneys Govern Bones" to Chronic Kidney Disease, Diabetes Mellitus, and Metabolic Bone Disorder: A Crosstalk between Traditional Chinese Medicine and Modern Science.

Authors:  Xiao-Qin Wang; Xin-Rong Zou; Yuan Clare Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-07       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.